Postoperative Effects of TAP Block Versus QLB Type 2 Block

November 11, 2017 updated by: Bozyaka Training and Research Hospital

Comparison of Postoperative Analgesic Effects of Transversus Abdominis Plane Block and Quadratus Lumborum Block Type 2

This study compares analgesic effectiveness of transversus abdominis plane block and quadratus lumborum block type 2 in open hernia repair surgery. All of the patients will receive routine intravenous analgesic regimen. In addition to that one-third of the patients will receive transversus abdominis plane block, one-third will receive quadratus lumborum block type 2. One-third of the patients will not receive any blocks and will constitute the control group

Study Overview

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Izmir, Turkey, 35170
        • Izmir Bozyaka Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who are over 18 years of age
  • Patients who are scheduled for elective unilateral open hernia repair with tension free mesh techniques
  • Patients who are in ASA's physical status score group 1 or 2

Exclusion Criteria:

  • Patients who are younger than 18 years of age
  • Patients who have severe stenotic heart diseases
  • Patients who have bleeding diathesis
  • Patients who have true allergies to local anesthetics
  • Patients who have neurologic deficits corresponding to effect site of the anesthetic techniques

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: TAP

Patients will undergo inguinal hernia repair under subarachnoid block with 0.5% bupivacaine+glucose.

Patients will receive transversus abdominis plane block with 20 ml of 0.25% bupivacaine preoperatively, in addition to intravenous acetaminophen 1000mg twice a day for postoperative analgesia.

Tramadol HCl 50mg intramuscular will be provided for salvage analgesia postoperatively.

1000 mg of intravenous acetaminophen will be administered twice a day
Other Names:
  • Postoperative routine analgesia
20 ml of 0.25% bupivacaine will be administered to the fascia of the transversus abdominis muscle under ultrasound guidance.
Other Names:
  • Transversus abdominis plane block
15mg of 0.5% bupivacaine will be administered to subarachnoid space through 25G spinal needle
Other Names:
  • Subarachnoid Block
50mg of intramuscular tramadol will be administered when pain score is greater than 3 according to NRS
Other Names:
  • Postoperative Salvage Analgesia
Patients will undergo open inguinal hernia repair with one of the tension free mesh techniques
10 ml 0.25% bupivacaine will be administered quadratus lumborum muscle and erector spinae muscle
Other Names:
  • Quadratus lumborum block type 2
Active Comparator: QLB2

Patients will undergo inguinal hernia repair under subarachnoid block with 0.5% bupivacaine+glucose.

Patients will receive quadratus lumborum type 2 block with 20 ml of %0.25 bupivacaine preoperatively, in addition to intravenous acetaminophen 1000mg twice a day for postoperative analgesia.

Tramadol HCl 50mg intramuscular will be provided for salvage analgesia postoperatively.

1000 mg of intravenous acetaminophen will be administered twice a day
Other Names:
  • Postoperative routine analgesia
20 ml of 0.25% bupivacaine will be administered to the fascia of the transversus abdominis muscle under ultrasound guidance.
Other Names:
  • Transversus abdominis plane block
15mg of 0.5% bupivacaine will be administered to subarachnoid space through 25G spinal needle
Other Names:
  • Subarachnoid Block
50mg of intramuscular tramadol will be administered when pain score is greater than 3 according to NRS
Other Names:
  • Postoperative Salvage Analgesia
Patients will undergo open inguinal hernia repair with one of the tension free mesh techniques
10 ml 0.25% bupivacaine will be administered quadratus lumborum muscle and erector spinae muscle
Other Names:
  • Quadratus lumborum block type 2
Active Comparator: CONT

Patients will undergo inguinal hernia repair under subarachnoid block with 0.5% bupivacaine+glucose.

Patients will receive intravenous acetaminophen 1000mg twice a day for postoperative analgesia.

Tramadol HCl 50mg intramuscular will be provided for salvage analgesia postoperatively.

1000 mg of intravenous acetaminophen will be administered twice a day
Other Names:
  • Postoperative routine analgesia
15mg of 0.5% bupivacaine will be administered to subarachnoid space through 25G spinal needle
Other Names:
  • Subarachnoid Block
50mg of intramuscular tramadol will be administered when pain score is greater than 3 according to NRS
Other Names:
  • Postoperative Salvage Analgesia
Patients will undergo open inguinal hernia repair with one of the tension free mesh techniques

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity
Time Frame: 24 hours after surgery
Postoperative pain intensity according Numeric Rating Scale between 0-10 (0=no pain, 10=worst pain ever
24 hours after surgery
Pain Intensity
Time Frame: 2 hours after surgery
Postoperative pain intensity according Numeric Rating Scale between 0-10 (0=no pain, 10=worst pain ever)
2 hours after surgery
Pain Intensity
Time Frame: 6 hours after surgery
Postoperative pain intensity according Numeric Rating Scale between 0-10 (0=no pain, 10=worst pain ever
6 hours after surgery
Pain Intensity
Time Frame: 48 hours after surgery
Postoperative pain intensity according Numeric Rating Scale between 0-10 (0=no pain, 10=worst pain ever
48 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2017

Primary Completion (Actual)

November 11, 2017

Study Completion (Actual)

November 11, 2017

Study Registration Dates

First Submitted

April 20, 2017

First Submitted That Met QC Criteria

April 20, 2017

First Posted (Actual)

April 24, 2017

Study Record Updates

Last Update Posted (Actual)

November 14, 2017

Last Update Submitted That Met QC Criteria

November 11, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Acetaminophen

3
Subscribe